Piperidine → HCID 11280537, compound
Reaction equation
[N:1]1([CH2:7][C:8]#[C:9][C:10]2[C:15]3[N:16]([C:19]4[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=4)[CH:17]=[N:18][C:14]=3[CH:13]=[C:12]([C:25]([F:28])([F:27])[F:26])[CH:11]=2)[CH2:6][CH2:5]O[CH2:3][CH2:2]1.N1CCCC[CH2:30]1>>[C:19]1([N:16]2[C:15]3[C:10]([C:9]#[C:8][CH2:7][N:1]4[CH2:6][CH2:5][CH2:30][CH2:3][CH2:2]4)=[CH:11][C:12]([C:25]([F:28])([F:27])[F:26])=[CH:13][C:14]=3[N:18]=[CH:17]2)[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=1Participants
3
Procedure
This was prepared in a similar manner to 7-(3-(4-morpholinyl)prop-1-ynyl)-1-phenyl-5-trifluoromethylbenzimidazole using piperidine in place of morpholine to realise the desired product (13 mg, 17%) m/z, 384.4 (M+H)+.
Sources & evidence
- ORD record
- ord-061b211c7469476aaae218018f487c6e
- Source dataset
- uspto-grants-2010_04
- Patent number
- US07700638B2
Reaction notes
Loading…